Bank of New York Mellon
FATE icon

Bank of New York Mellon’s Fate Therapeutics FATE Stock Holding History

Bank of New York Mellon’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.7K Sell
11,381
-295,606
-96% -$547K ﹤0.01% 4254
2026
Q1 		$368K Sell
306,987
-610
-0.2% -$743 ﹤0.01% 3742
2025
Q4 		$302K Sell
307,597
-8,739
-3% -$10.5K ﹤0.01% 3853
2025
Q3 		$399K Buy
316,336
+25,684
+9% +$27.7K ﹤0.01% 3724
2025
Q2 		$326K Sell
290,652
-1,103
-0.4% -$1.28K ﹤0.01% 3752
2025
Q1 		$231K Sell
291,755
-1,251
-0.4% -$1.53K ﹤0.01% 3826
2024
Q4 		$483K Sell
293,006
-6,280
-2% -$15.8K ﹤0.01% 3547
2024
Q3 		$1.05M Sell
299,286
-74,846
-20% -$291K ﹤0.01% 3119
2024
Q2 		$1.23M Buy
374,132
+72,139
+24% +$316K ﹤0.01% 3076
2024
Q1 		$2.22M Sell
301,993
-19,959
-6% -$124K ﹤0.01% 2711
2023
Q4 		$1.2M Buy
321,952
+9,164
+3% +$21.6K ﹤0.01% 3092
2023
Q3 		$663K Sell
312,788
-10,852
-3% -$36K ﹤0.01% 3403
2023
Q2 		$1.54M Sell
323,640
-31,552
-9% -$174K ﹤0.01% 2973
2023
Q1 		$2.02M Sell
355,192
-7,882
-2% -$47.6K ﹤0.01% 2797
2022
Q4 		$3.66M Sell
363,074
-27,195
-7% -$511K ﹤0.01% 2516
2022
Q3 		$8.75M Buy
390,269
+39,739
+11% +$1.15M ﹤0.01% 1970
2022
Q2 		$8.69M Sell
350,530
-4,419
-1% -$122K ﹤0.01% 2024
2022
Q1 		$13.8M Sell
354,949
-3,446
-1% -$133K ﹤0.01% 1894
2021
Q4 		$21M Buy
358,395
+15,085
+4% +$855K ﹤0.01% 1701
2021
Q3 		$20.3M Buy
343,310
+15,842
+5% +$1.24M ﹤0.01% 1718
2021
Q2 		$28.4M Buy
327,468
+23,128
+8% +$1.86M 0.01% 1528
2021
Q1 		$25.1M Sell
304,340
-10,883
-3% -$1.04M 0.01% 1569
2020
Q4 		$28.7M Sell
315,223
-1,036
-0.3% -$64.3K 0.01% 1408
2020
Q3 		$12.6M Buy
316,259
+32,774
+12% +$1.14M ﹤0.01% 1723
2020
Q2 		$9.73M Sell
283,485
-16
-0% -$477 ﹤0.01% 1854
2020
Q1 		$6.3M Buy
283,501
+44,992
+19% +$1.14M ﹤0.01% 1957
2019
Q4 		$4.67M Buy
238,509
+19,993
+9% +$318K ﹤0.01% 2373
2019
Q3 		$3.39M Sell
218,516
-13,139
-6% -$252K ﹤0.01% 2468
2019
Q2 		$4.7M Sell
231,655
-19,232
-8% -$347K ﹤0.01% 2361
2019
Q1 		$4.41M Buy
250,887
+5,375
+2% +$84.8K ﹤0.01% 2395
2018
Q4 		$3.15M Sell
245,512
-21,263
-8% -$296K ﹤0.01% 2516
2018
Q3 		$4.34M Sell
266,775
-23,754
-8% -$281K ﹤0.01% 2473
2018
Q2 		$3.29M Buy
290,529
+13,839
+5% +$152K ﹤0.01% 2590
2018
Q1 		$2.7M Buy
276,690
+124,201
+81% +$1.19M ﹤0.01% 2655
2017
Q4 		$931K Sell
152,489
-448
-0.3% -$2K ﹤0.01% 3292
2017
Q3 		$606K Sell
152,937
-4,609
-3% -$15.7K ﹤0.01% 3486
2017
Q2 		$511K Buy
157,546
+98,036
+165% +$376K ﹤0.01% 3586
2017
Q1 		$271K Buy
59,510
+952
+2% +$3.48K ﹤0.01% 3782
2016
Q4 		$147K Sell
58,558
-2,572
-4% -$6.88K ﹤0.01% 3959
2016
Q3 		$191K Sell
61,130
-7,314
-11% -$17.7K ﹤0.01% 3903
2016
Q2 		$117K Buy
68,444
+4,941
+8% +$8.96K ﹤0.01% 4020
2016
Q1 		$114K Buy
63,503
+75
+0.1% +$154 ﹤0.01% 3936
2015
Q4 		$213K Hold
63,428
– – ﹤0.01% 3851
2015
Q3 		$338K Buy
63,428
+21,662
+52% +$148K ﹤0.01% 3730
2015
Q2 		$270K Buy
41,766
+3,323
+9% +$19.9K ﹤0.01% 3811
2015
Q1 		$188K Hold
38,443
– – ﹤0.01% 3906
2014
Q4 		$193K Hold
38,443
– – ﹤0.01% 3900
2014
Q3 		$196K Hold
38,443
– – ﹤0.01% 3901
2014
Q2 		$242K Buy
38,443
+43
+0.1% +$303 ﹤0.01% 3793
2014
Q1 		$374K Buy
+38,400
New +$297K ﹤0.01% 3667

Other funds holding FATE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Bank of New York Mellon's FATE Position: Q2 2026 in Review

Bank of New York Mellon reduced its Fate Therapeutics (FATE) stake by 96% in Q2 2026, selling an estimated $547K and leaving 11,381 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4254.

Bank of New York Mellon first reported a position in FATE in Q1 2014 and has held it in 50 quarters since. The position peaked at $28.7M in Q4 2020. 53 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Bank of New York Mellon held 11,381 shares of Fate Therapeutics worth $30.7K as of Q2 2026.
  • Bank of New York Mellon sold 295,606 Fate Therapeutics shares in Q2 2026, an estimated $547K.
  • Fate Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4254 holding.
  • Bank of New York Mellon first reported a position in Fate Therapeutics in Q1 2014 and has held it in 50 quarters since.
  • Bank of New York Mellon's Fate Therapeutics position peaked at $28.7M in Q4 2020.
  • 53 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.